Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

POZEN Inc (NASDAQ:POZN)

11.70
Delayed Data
As of Jul 29
 -0.475 / -3.90%
Today’s Change
5.96
Today|||52-Week Range
12.69
+46.19%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$394.0M

Company Description

POZEN, Inc. is a pharmaceutical company, which manufactures and markets pharmaceutical products. The company's Pipeline products are PA Product Portfolio, which is focused on integrated aspirin therapies that enable the full power of aspirin by reducing its potential gastrointestinal damage. PA Product Portfolio consists of PA8140 and PA32540. Its licensed products include Treximet, MT 400 and VIMOVO. POZEN was founded by John R. Plachetka on September 25, 1996 and is headquartered in Chapel Hill, NC.

Contact Information

POZEN, Inc.
1414 Raleigh Road
Chapel Hill North Carolina 27517
P:(919) 913-1030
Investor Relations:
(919) 913-1074

Employees

Shareholders

Other institutional41.39%
Individual stakeholders38.67%
Mutual fund holders17.35%

Top Executives

Adrian AdamsChief Executive Officer & Director
Andrew I. KovenPresident & Chief Business Officer
William L. HodgesCFO, Senior VP-Finance & Administration
John G. FortChief Medical Officer
Dennis L. McNamaraChief Business Officer & Senior Vice President